16.05.2014 Views

Legaliseringsguiden, genomgång av ... - PDF Archive

Legaliseringsguiden, genomgång av ... - PDF Archive

Legaliseringsguiden, genomgång av ... - PDF Archive

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

“<br />

"Our<br />

results indicate that cannabinoid receptors are important in the pathology of<br />

AD and that cannabinoids succeed in preventing the neurodegenerative process<br />

occurring in the disease."<br />

— Prevention of Alzheimer's Disease Pathology by Cannabinoids:<br />

Neuroprotection Mediated by Blockade of Microglial Activation [5] ”<br />

I uppföljande studier bekräftar forskare att administrering <strong>av</strong> bl.a den ickepsykoaktiva cannabinoiden<br />

cannabidiol (CBD) också skapar en lindring <strong>av</strong> minnesförlusten och har antiinflammatoriska<br />

egenskaper.<br />

“<br />

"CBD<br />

is able to modulate microglial cell function in vitro and induce beneficial effects<br />

in an in vivo model of AD. Given that CBD lacks psychoactivity, it may represent a<br />

novel therapeutic approach for this neurological disease."<br />

— Cannabidiol and other cannabinoids reduce microglial activation in vitro<br />

and in vivo: relevance to Alzheimer's disease [6] ”<br />

“<br />

"The<br />

results of the present study confirm in vivo anti-inflammatory actions of CBD,<br />

emphasizing the importance of this compound as a novel promising pharmacological<br />

tool capable of attenuating beta-amyloid evoked neuroinflammatory responses."<br />

— Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by<br />

suppressing IL-1beta and iNOS expression [7] ”<br />

“<br />

"Our<br />

results emphasize the potential use of CBr agonists in the regulation of<br />

inflammatory processes within the brain; this knowledge may lead to the use of CBr<br />

agonists in the treatment of neurodegenerative diseases associated with chronic<br />

neuroinflammation, such as Alzheimer disease"<br />

— Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a<br />

rodent model of chronic brain inflammation [8] ”<br />

Forskare i USA rapporterade 2006 om att THC hämmar enzymen som är ansvariga för uppbyggnaden<br />

<strong>av</strong> beta-amyloid peptid i plack effektivare än vanliga alzheimersmediciner som Donepezil och Takrin.<br />

“<br />

"It<br />

is noteworthy that THC is a considerably more effective inhibitor of AChE-induced<br />

Aβ deposition than the approved drugs for Alzheimer's disease treatment, donepezil<br />

and tacrine, which reduced Aβ aggregation by only 22% and 7%, respectively, at<br />

twice the concentration used in our studies.7 Therefore, AChE inhibitors such as THC<br />

and its analogues may provide an improved therapeutic for Alzheimer's disease,<br />

augmenting acetylcholine levels by preventing neurotransmitter degradation and<br />

reducing Aβ aggregation, thereby simultaneously treating both the symptoms and<br />

progression of Alzheimer's disease."<br />

— A Molecular Link Between the Active Component of Marijuana and<br />

Alzheimer's Disease Pathology [9]<br />

”<br />

Det finns därtill ett antal studier som påvisar att cannabinoider kan reducera stress och leda till en<br />

viktuppgång för patienter med sjukdomen. Forskare vid Charite Universitätmedizin i Berlin<br />

125

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!